<<BACK TO NINTH GAVI BOARD MEETING

NINTH GAVI BOARD MEETING
Dakar, 18-19 November 2002

11 Vaccine Vial Monitors

Paper (Word - 28K)

Discussion

  • The Board recognized that there are many complex issues related to the adoption of vaccine vial monitors (VVM) but reiterated its conviction that VVMs provide an important safety and quality-control benefit.


DECISIONS

The Board:

  • 1.1 Requested that the minutes of the March 2002 meeting with manufacturers be circulated to the Board.


  • 1.2 Recommended immediate intensive action by appropriate GAVI Partners to accelerate the implementation of VVMs, consistent with ensuring vaccine security.


  • 1.3 Resolved as an objective that all vaccines supported by the Vaccine Fund will include VVMs after 2003.


  • 1.4 Urged all national and international agencies procuring vaccines to include VVMs as a requirement latest as of 2004, so the full programmatic benefits of VVMs can be realized.


  • 1.5 Urged vaccine manufacturers to complete the preparation needed to provide all vaccines with VVMs within a stated time schedule, but no later than end-2003.


  • 1.6 Requested vaccine industry members of the GAVI Board to provide at its first meeting in 2003 an update on action taken.


<<BACK TO NINTH GAVI BOARD MEETING

spacer

Copyright © GAVI